גיל המעבר טיפול טבעי
תוספי תזונה וצמחי מרפא - מה חשוב שתדעי ותכירי?

[1] The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety’.

[2]  The 2023 nonhormone therapy position statement of The North American Menopause Society’, Menopause, vol. 30, no. 6, pp. 573–590, Jun. 2023, doi: 10.1097/GME.0000000000002200.

[3] R. Kargozar, H. Azizi, and R. Salari, ‘A review of effective herbal medicines in controlling menopausal symptoms’, Electron Physician, vol. 9, no. 11, pp. 5826–5833, Nov. 2017, doi: 10.19082/5826.

[4]  Benefits of Black Cohosh (Cimicifuga racemosa) for Women Health: An Up-Close and In-Depth Review’.

[5]  M. J. Leach and V. Moore, ‘Black cohosh (Cimicifuga spp.) for menopausal symptoms.’, Cochrane Database Syst Rev, vol. 2012, no. 9, p. CD007244, Sep. 2012, doi: 10.1002/14651858.CD007244.pub2.

[6] Nonhormonal management of menopause-associated vasomotor symptoms’, Menopause, vol. 22, no. 11, pp. 1155–1174, Nov. 2015, doi: 10.1097/GME.0000000000000546.

[7] The Effect of Vitamin E on Hot Flashes in Menopausal Women’.

[8] W. Thongchumnum, S. A.-O. Vallibhakara, A. Sophonsritsuk, and O. Vallibhakara, ‘Effect of Vitamin E Supplementation on Chronic Insomnia Disorder in Postmenopausal Women: A Prospective, Double-Blinded Randomized Controlled Trial’, Nutrients, vol. 15, no. 5, p. 1187, Feb. 2023, doi: 10.3390/nu15051187.

[9]D. L. Barton et al., ‘Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.’, Journal of Clinical Oncology, vol. 16, no. 2, pp. 495–500, Feb. 1998, doi: 10.1200/JCO.1998.16.2.495.

[10] The Effect of Vitamin E Supplementation in Postmenopausal Women—A Systematic Review’.

[11]P. Anagnostis et al., ‘EMAS position statement: Vitamin D and menopausal health.’, Maturitas, vol. 169, pp. 2–9, Mar. 2023, doi: 10.1016/j.maturitas.2022.12.006.

[12]A. M. Malutan, M. Dan, C. Nicolae, and M. Carmen, ‘Proinflammatory and anti-inflammatory cytokine changes related to menopause.’, Prz Menopauzalny, vol. 13, no. 3, pp. 162–8, Jun. 2014, doi: 10.5114/pm.2014.43818.

[13]F. Kazemi, S. Z. Masoumi, A. Shayan, and K. Oshvandi, ‘The Effect of Evening Primrose Oil Capsule on Hot Flashes and Night Sweats in Postmenopausal Women: A Single-Blind Randomized Controlled Trial’, J Menopausal Med, vol. 27, no. 1, p. 8, 2021, doi: 10.6118/jmm.20033.

[14] W. Kanadys et al., ‘Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.’, Nutrients, vol. 13, no. 4, Apr. 2021, doi: 10.3390/nu13041258.

[15]Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study’.

[16]U. Gröber, J. Schmidt, and K. Kisters, ‘Magnesium in Prevention and Therapy.’, Nutrients, vol. 7, no. 9, pp. 8199–226, Sep. 2015, doi: 10.3390/nu7095388.

[17]J. Vormann, ‘Magnesium: nutrition and metabolism’, Mol Aspects Med, vol. 24, no. 1–3, pp. 27–37, Feb. 2003, doi: 10.1016/S0098-2997(02)00089-4.

[18]  M. Szkup et al., ‘Analysis of Relations Between the Level of Mg, Zn, Ca, Cu, and Fe and Depressiveness in Postmenopausal Women’, Biol Trace Elem Res, vol. 176, no. 1, pp. 56–63, Mar. 2017, doi: 10.1007/s12011-016-0798-9.

[19]D. Phelan, P. Molero, M. A. Martínez-González, and M. Molendijk, ‘Magnesium and mood disorders: systematic review and meta-analysis’, BJPsych Open, vol. 4, no. 4, pp. 167–179, Jul. 2018, doi: 10.1192/bjo.2018.22.

[20]S. Castiglioni, A. Cazzaniga, W. Albisetti, and J. Maier, ‘Magnesium and Osteoporosis: Current State of Knowledge and Future Research Directions’, Nutrients, vol. 5, no. 8, pp. 3022–3033, Jul. 2013, doi: 10.3390/nu5083022.

[21] [Levels of ionized magnesium in women with various stages of postmenopausal osteoporosis progression evaluated on the basis of densitometric examinations].’.

[22] M. Mutlu, M. Argun, E. Kilic, R. Saraymen, and S. Yazar, ‘Magnesium, Zinc and Copper Status in Osteoporotic, Osteopenic and Normal Post-menopausal Women’, Journal of International Medical Research, vol. 35, no. 5, pp. 692–695, Sep. 2007, doi: 10.1177/147323000703500514.

[23] G.-C. M. Gast et al., ‘Menopausal Complaints Are Associated With Cardiovascular Risk Factors’, Hypertension, vol. 51, no. 6, pp. 1492–1498, Jun. 2008, doi: 10.1161/HYPERTENSIONAHA.107.106526.

[24] R. C. Thurston et al., ‘Vasomotor symptoms and insulin resistance in the study of women’s health across the nation.’, J Clin Endocrinol Metab, vol. 97, no. 10, pp. 3487–94, Oct. 2012, doi: 10.1210/jc.2012-1410.

[25]  R. C. Thurston, K. Sutton-Tyrrell, S. A. Everson-Rose, R. Hess, and K. A. Matthews, ‘Hot Flashes and Subclinical Cardiovascular Disease’, Circulation, vol. 118, no. 12, pp. 1234–1240, Sep. 2008, doi: 10.1161/CIRCULATIONAHA.108.776823.

[26] Oral magnesium oxide for treatment of hot flashes in women undergoing treatment for breast cancer: A pilot study.’.

[27] C. W. Tsao et al., ‘Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association’, Circulation, vol. 145, no. 8, Feb. 2022, doi: 10.1161/CIR.0000000000001052.

[28] R. Lima, M. Wofford, and J. F. Reckelhoff, ‘Hypertension in Postmenopausal Women’, Curr Hypertens Rep, vol. 14, no. 3, pp. 254–260, Jun. 2012, doi: 10.1007/s11906-012-0260-0.

[29] J. Staessen, G. Ginocchio, L. Thijs, and R. Fagard, ‘Conventional and ambulatory blood pressure and menopause in a prospective population study’, J Hum Hypertens, vol. 11, no. 8, pp. 507–514, Aug. 1997, doi: 10.1038/sj.jhh.1000476.

[30] N. K. Wenger et al., ‘Hypertension Across a Woman’s Life Cycle’, J Am Coll Cardiol, vol. 71, no. 16, pp. 1797–1813, Apr. 2018, doi: 10.1016/J.JACC.2018.02.033.

[31]  The menopause transition and women’s health at midlife: a progress report from the Study of Women’s Health Across the Nation (SWAN)’.

[32]  H. Han et al., ‘Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies’, Nutr J, vol. 16, no. 1, p. 26, Dec. 2017, doi: 10.1186/s12937-017-0247-4.

[33]  A. R. Cunha et al., ‘Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women’, J Hypertens, vol. 35, no. 1, pp. 89–97, Jan. 2017, doi: 10.1097/HJH.0000000000001129.

[34] M. D. van Die, H. G. Burger, H. J. Teede, and K. M. Bone, ‘Vitex agnus-castus (Chaste-Tree/Berry) in the Treatment of Menopause-Related Complaints’, The Journal of Alternative and Complementary Medicine, vol. 15, no. 8, pp. 853–862, Aug. 2009, doi: 10.1089/acm.2008.0447.

[35] M. Mohammady, L. Janani, S. Jahanfar, and M. S. Mousavi, ‘Effect of omega-3 supplements on vasomotor symptoms in menopausal women: A systematic review and meta-analysis’, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 228, pp. 295–302, Sep. 2018, doi: 10.1016/j.ejogrb.2018.07.008.

[36] D. Decandia, E. Landolfo, S. Sacchetti, F. Gelfo, L. Petrosini, and D. Cutuli, ‘n-3 PUFA Improve Emotion and Cognition during Menopause: A Systematic Review.’, Nutrients, vol. 14, no. 9, May 2022, doi: 10.3390/nu14091982.